By: N. Granacher MD
The annual EHA meeting again featured several interesting oral abstracts and poster presentations in the field of myeloproliferative neoplasms (MPN). Below the highlights in Philadelphia positive (Ph+) chronic myeloid leukaemia (CML), Philadelphia negative MPN, polycythemia vera (PV) and myelofibrosis are summarised.
(BELG J HEMATOL 2024;15(5):197–200)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
